ÎÚÑ»´«Ã½

Associate Professor, International Health 
Global Disease Epidemiology and Control Program

The Department of International is pleased to welcome Naor Bar-Zeev, PhD, MBBS(Hons), MPH, MBiostat. Dr. Bar-Zeev joins the Department's Global Disease Epidemiology and Control (GDEC) Program and the  Dr. Bar-Zeev’s work in IVAC will include serving as lead investigator on a seven-country randomized clinical trial of azithromycin in childhood diarrhea and as co-investigator on a randomized trial of a novel neonatal rotavirus vaccine, as well as establishing a typhoid cost-of-illness study in Malawi, in collaboration with PATH.

Dr. Bar-Zeev brings 20 years of experience in global child health across East Asia, the Pacific, and Africa. Prior to joining the Bloomberg School, Dr. Bar-Zeev was a Reader (Associate Professor) in Pediatric Infectious Diseases at the  While in Malawi, he worked as a vaccine epidemiologist at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, where he led the Vaccines Research Group, and as a pediatric infectious diseases specialist at the Queen Elizabeth Central Hospital. In 2011, Dr. Bar-Zeev helped establish VacSurv, a multi-site national vaccine surveillance program in Malawi. Prior to his work in Malawi, Dr. Bar-Zeev worked in Darwin, Australia, and with the Western Pacific Regional Office of the  in Mongolia, Cambodia and the Pacific. He has also worked in Kenya, Tanzania, and Vietnam.

Contributor: Swati Sudarsan, Advocacy and Communications Specialist, IVAC